🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 15 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
08/09/2014 22,82 23,19 22,70 23,11 +0,92% 2,15% 832.900
05/09/2014 23,27 23,32 22,25 22,90 -1,63% 4,60% 1.082.100
04/09/2014 22,59 25,41 22,22 23,28 +3,70% 14,12% 4.738.100
03/09/2014 22,69 22,87 22,17 22,45 -0,49% 3,09% 643.700
02/09/2014 22,92 23,45 21,92 22,56 -1,61% 6,68% 867.200
29/08/2014 22,20 22,97 22,07 22,93 +3,62% 4,05% 689.600
28/08/2014 22,71 23,35 22,06 22,13 -3,11% 5,68% 821.900
27/08/2014 23,21 23,75 22,75 22,84 -1,55% 4,31% 632.600
26/08/2014 22,57 23,35 22,34 23,20 +3,11% 4,47% 868.000
25/08/2014 21,95 22,92 21,95 22,50 +3,64% 4,42% 906.700
22/08/2014 21,45 21,73 20,95 21,71 +1,02% 3,64% 717.000
21/08/2014 21,72 22,11 21,39 21,49 -1,06% 3,31% 517.500
20/08/2014 22,29 22,51 21,57 21,72 -2,86% 4,22% 610.500
19/08/2014 22,80 22,80 21,88 22,36 +0,04% 4,04% 481.400
18/08/2014 22,67 22,83 22,23 22,35 -0,53% 2,65% 429.200
15/08/2014 22,48 22,93 21,78 22,47 +0,49% 5,12% 783.000
14/08/2014 22,34 22,70 22,05 22,36 +0,04% 2,91% 615.300
13/08/2014 21,49 22,59 21,45 22,35 +4,63% 5,30% 1.174.900
12/08/2014 22,30 22,48 21,15 21,36 -5,74% 5,96% 1.049.200
11/08/2014 21,45 22,83 21,05 22,66 +7,39% 8,30% 1.504.400
08/08/2014 20,13 21,12 19,86 21,10 +6,03% 6,26% 1.102.100
07/08/2014 21,51 21,59 19,64 19,90 -8,84% 9,07% 2.145.600
06/08/2014 22,50 22,50 21,72 21,83 -3,06% 3,47% 920.100
05/08/2014 22,60 22,80 21,92 22,52 +2,50% 3,89% 1.723.400
04/08/2014 22,09 22,22 21,07 21,97 +0,00% 5,21% 1.015.600
01/08/2014 21,61 22,19 20,63 21,97 +2,95% 7,22% 1.603.500
31/07/2014 22,44 22,67 21,31 21,34 -6,93% 6,06% 1.429.700
30/07/2014 23,05 23,79 22,30 22,93 +12,79% 6,46% 2.835.200
29/07/2014 20,15 20,91 19,90 20,33 +2,16% 5,01% 1.912.400
28/07/2014 20,71 20,78 19,33 19,90 -3,30% 7,00% 1.285.800